Vpriv Injection, Powder, Lyophilized, For Solution
Product Images NDC 54092-701

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Vpriv (NDC 54092-701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vpriv 01

This is a description of VPRIV (velaglucerase alfa), an injectable medication used for intravenous use only. Following reconstitution with Sterile Water for Injection, USP, the resultant concentration s 100 units/mL. It must be refrigerated, stored at 2ºC to 8ºC. Each single-dose vial contains 400 units of velaglucerase alfa and other ingredients. VPRIV is made by Takeda Pharmaceuticals and is a registered trademark of Shire Human Genetic Therapies, Inc. Dosage instructions are available in the prescribing information. Contact 1-800-828-2088 for questions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.